From tumour suppression to insulin resistance
Nature Medicine
August 31, 2009
The tumour suppressor p53 is crucial for the development of insulin resistance, a hallmark of diabetes, reports a study in this week's Nature Medicine.
Issei Komuro and his colleagues found that excessive calorie intake led to inflammation, insulin resistance and increased expression of p53 in mice. Inhibition of p53 activity specifically in fat tissue, decreased the inflammatory response and improved insulin resistance. Conversely, forced expression of p53 in the fat caused an inflammatory response that led to insulin resistance, and fat tissue from patients with diabetes showed similar responses.
These results illustrate a new role for p53 in the regulation of insulin resistance, raising the possibility that cellular changes linked to p53 activity could be new targets for the treatment of diabetes.
doi: 10.1038/nm.2014
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature